NSEClarification - Financial Results24 Jun 2026 · 24 Jun 2026, 09:01 am

Clarification - Financial Results

BALAXI PHARMACEUTICALS LIMITED · BALAXI

✦ AI SummaryResults

The NSE has sought clarification from Balaxi Pharmaceuticals regarding its financial results for the quarter ended 31-Mar-2026 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange has sought clarification from BALAXI PHARMACEUTICALS LIMITED for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.